
Debbie Wasserman Schultz Periodic Transaction Report
Filed Jul 1, 2024 · House Clerk · 1 transaction
U.S. Representative · D · FL-25 · All trades by Debbie Wasserman Schultz
On July 1, 2024, Rep. Debbie Wasserman Schultz (D-FL-25) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Dec 18, 2023.
The filing covers 1 ticker, including $FEI.
Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.
1 trade was reported more than 45 days after the trade date, outside the STOCK Act's 45-day window. The longest lag in this filing was 196 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20025360
Sample · the intelligence layer
Debbie Wasserman Schultz · Sold $FEI · Dec 18 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Debbie Wasserman Schultz
Get an email the moment Debbie Wasserman Schultz files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Dec 18, 2023 | FEIFEIFirst Trust MLP and Energy Income Fund Common Shares of Beneficial Interest (FEI) [ST] | First Trust MLP and Energy Income Fund Common Shares of Beneficial Interest (FEI) [ST] | sell | Dependent Child | $1K–$15K | 196d |
Other recent filings by Debbie Wasserman Schultz
- PTR filed Jul 14, 20261 trade · ICHR
- PTR filed Dec 8, 20251 trade · INVX
- PTR filed Oct 24, 20251 trade · ANGO
- PTR filed Oct 6, 20251 trade · BRY
- PTR filed Oct 6, 20252 trades · BRY, VLRS
- PTR filed Aug 18, 20251 trade · SSYS
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →